A 2-stage Phase II study evaluating the safety and efficacy of combination pomalidomide and low dose dexamethasone therapy in patients with relapsed myeloma previously treated wtih lenalidomide maintenance post Autologous Stem Cell Transplant (LEOPARD follow-on study)
Safety and tolerability of lenalidomide consolidation post allogeneic stem cell transplant for patients with high risk multiple myeloma failing to achieve stringent Complete Response
100 Clinical Results associated with Celgene Pty Ltd.
0 Patents (Medical) associated with Celgene Pty Ltd.
100 Deals associated with Celgene Pty Ltd.
100 Translational Medicine associated with Celgene Pty Ltd.